These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34278505)

  • 1. TMEM100 negatively regulated by microRNA‑106b facilitates cellular apoptosis by suppressing survivin expression in NSCLC.
    Ma J; Yan T; Bai Y; Ye M; Ma C; Ma X; Zhang L
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34278505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMEM100 induces cell death in non‑small cell lung cancer via the activation of autophagy and apoptosis.
    He Q; Dong Y; Zhu Y; Ding Z; Zhang X; Wang Z; Ai R; He Y
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 34184748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase 6-mediated downregulation of TMEM100 expedites the development and progression of non-small cell lung cancer.
    Wang Y; Ha M; Li M; Zhang L; Chen Y
    Hum Cell; 2022 Jan; 35(1):271-285. PubMed ID: 34687431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TMEM229A suppresses non‑small cell lung cancer progression via inactivating the ERK pathway.
    Zhang X; He Y; Jiang Y; Bao Y; Chen Q; Xie D; Yu H; Wang X
    Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
    Guo D; Wang Y; Ren K; Han X
    Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
    Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
    BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-193b availability is antagonized by LncRNA-SNHG7 for FAIM2-induced tumour progression in non-small cell lung cancer.
    She K; Yan H; Huang J; Zhou H; He J
    Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29131440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PA28gamma emerges as a novel functional target of tumour suppressor microRNA-7 in non-small-cell lung cancer.
    Xiong S; Zheng Y; Jiang P; Liu R; Liu X; Qian J; Gu J; Chang L; Ge D; Chu Y
    Br J Cancer; 2014 Jan; 110(2):353-62. PubMed ID: 24281003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-138 acts as a tumor suppressor in non small cell lung cancer via targeting YAP1.
    Xiao L; Zhou H; Li XP; Chen J; Fang C; Mao CX; Cui JJ; Zhang W; Zhou HH; Yin JY; Liu ZQ
    Oncotarget; 2016 Jun; 7(26):40038-40046. PubMed ID: 27223073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT1-induced upregulation of lncRNA KTN1-AS1 predicts poor prognosis and facilitates non-small cell lung cancer progression via miR-23b/DEPDC1 axis.
    Liu C; Li X; Hao Y; Wang F; Cheng Z; Geng H; Geng D
    Aging (Albany NY); 2020 May; 12(9):8680-8701. PubMed ID: 32396871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
    Sun CC; Li SJ; Zhang F; Pan JY; Wang L; Yang CL; Xi YY; Li de J
    Oncotarget; 2016 Apr; 7(16):21510-26. PubMed ID: 26909600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-195 targets cyclin D3 and survivin to modulate the tumorigenesis of non-small cell lung cancer.
    Yu X; Zhang Y; Cavazos D; Ma X; Zhao Z; Du L; Pertsemlidis A
    Cell Death Dis; 2018 Feb; 9(2):193. PubMed ID: 29416000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA FENDRR inhibits NSCLC cell growth and aggressiveness by sponging miR-761.
    Zhang MY; Zhang ZL; Cui HX; Wang RK; Fu L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8324-8332. PubMed ID: 30556873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
    Zheng J; Xu T; Chen F; Zhang Y
    Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-103 Functions as a Tumor Suppressor by Directly Targeting Programmed Cell Death 10 in NSCLC.
    Yang D; Wang JJ; Li JS; Xu QY
    Oncol Res; 2018 May; 26(4):519-528. PubMed ID: 28734041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-507 represses the malignant behaviors of non-small cell lung cancer via targeting zinc finger E-box binding homeobox 2.
    Lv HL; Li ZL; Song YB
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9955-9964. PubMed ID: 31799665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of LINC00261 inhibits non-small cell lung cancer cells progression by interacting with miR-522-3p and suppressing Wnt signaling.
    Shi J; Ma H; Wang H; Zhu W; Jiang S; Dou R; Yan B
    J Cell Biochem; 2019 Oct; 120(10):18378-18387. PubMed ID: 31190356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA miR-10b inhibition reduces cell proliferation and promotes apoptosis in non-small cell lung cancer (NSCLC) cells.
    Huang J; Sun C; Wang S; He Q; Li D
    Mol Biosyst; 2015 Jul; 11(7):2051-9. PubMed ID: 25988292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-7 inhibits the malignant phenotypes of non‑small cell lung cancer in vitro by targeting Pax6.
    Luo J; Li H; Zhang C
    Mol Med Rep; 2015 Oct; 12(4):5443-8. PubMed ID: 26135959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer.
    Lu YJ; Liu RY; Hu K; Wang Y
    Tumour Biol; 2016 Sep; 37(9):12685-12695. PubMed ID: 27448300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.